Sulforaphane

Research citations

Recent research mentioning Sulforaphane

1. A natural product-hybridization approach toward anticancer drug discovery: synthesis and antitumor evaluation of CTBC6, designed from sulforaphane and magnolol.
   Tao C, Chen M, Liu B, Chen H, Ji F · Bioorg Chem · 2026-06-05pubmed
2. The H(2)S donor sulforaphane inhibits NLRP(3) inflammasome activation by inducing mitochondrial autophagy and mitigating CBS-H(2)S axis damage in in-vitro and in-vivo models of Parkinson's disease.
   Xie W, Wu K, Zhang L, Feng X, Yang S · Bioorg Chem · 2026-06-01pubmed
3. Retraction notice to "Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme" [Brain Res. 1343 (2010) 178-185].
   Ping Z, Liu W, Kang Z, Cai J, Wang Q · Brain Res · 2026-05-01pubmed
4. Sulforaphane prevents abdominal aortic aneurysm formation through the inhibition of phenotypic switching of vascular smooth muscle cells and inflammation via the activation of Nrf2.
   Huang Z, Tao Y, Liu C, Wang J, Deng C · Cell Signal · 2026-04-04pubmed

Continuously updated by the research discovery pipeline. New citations appear automatically within a day of publication.

How it works

Sulforaphane is a phytochemical within the isothiocyanate group of organosulfur compounds.

Source: Wikipedia

Chemistry

IUPAC name

1-isothiocyanato-4-methylsulfinylbutane

Formula

C6H11NOS2

PubChem

CID 5350 →

Source: PubChem (NIH, public domain)

Learn more